,j.toxlet.2010.11.016.xml,C2JM31396K.pdf,nn101097v.pdf,j.biomaterials.2013.01.001.xml,acsomega.2c03171.xml,tx400385x.pdf,j.biomaterials.2012.07.040.xml,j.biomaterials.2012.05.064.xml,smll.201201546.pdf,nn202699t.pdf,nn1007176.pdf,A20060216.pdf,s11671-010-9751-6.xml,j.envpol.2017.12.034.xml,cdd.2010.11.pdf,nl202515a.pdf,smll.201102743.pdf,j.biomaterials.2012.02.021.xml,j.biomaterials.2012.11.001.xml,la203607w.pdf,am300253c.pdf,ijms221910578.xml
Adverse outcome, Cytotoxicity, Decreased cell viability, Reduced cell viability., Cytotoxicity, Pulmonary inflammation, Cytotoxicity, Cytotoxicity, Cytotoxicity, Cytotoxicity, Growth inhibition, Decreased cell viability, Cytotoxicity, DNA damage, Growth inhibition, Cytotoxicity, Cytotoxicity, Cytotoxicity, Cytotoxicity, Cytotoxicity, Reduced cell viability., Decreased cell viability, Cytotoxicity
Bioassay, MTT assay, MTT assay, MTT assay., MTT assay, Histopathological examination, MTT assay, MTT assay, MTT assay, MTT assay, Microscopic observation, MTT assay, MTT assay, Comet assay, Microbial growth inhibition assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay., MTT assay, MTT assay
Material diameter measurement, Particle size, Mean particle size, Average particle diameter., Particle size, Airway diameter, Particle size, Particle size, Particle size, Mean particle size, Cell diameter, Particle size, Particle size, Mean nuclear diameter, Colony diameter, Particle size, Average particle size, Particle size, Particle size, Particle size, Particle size., Particle size, Average particle size
Numerical value, 10 nm, 10.2 nm, 5.2 nm., 10 nm, 20%, 10 nm, 10 nm, 10 nm, 10.2 nm, 0.8 μm, 10 nm, 10.2, 8.2, 0.5, 10 nm, 10.2, 10.2, 10-20 nm, 10 nm, 10 nm., 10 nm, 10.2
Units, nanometers, nanometers, nanometers., nanometers, %, nanometers, nanometers, nanometers, nanometers, μm, nanometers, nm, μm, mm, nanometers, nm, nm, nanometers, nanometers, nanometers., nanometers, nm
Graphene oxide dose, units milligrams per milliliter, units milligrams per milliliter, units milligrams per milliliter., units milligrams per milliliter, units mg/kg, units milligrams per milliliter, units milligrams per milliliter, units milligrams per milliliter, units milligrams per milliliter, units mg/mL, units milligrams per milliliter, units mg/mL, units μg/mL, units mg/mL, units milligrams per milliliter, units mg/mL, units mg/mL, 0.1 mg/ml, units milligrams per milliliter, units milligrams per milliliter., units milligrams per milliliter, units mg/mL
Graphene oxide dose units, milligrams per milliliter, milligrams per milliliter, milligrams per milliliter., milligrams per milliliter, mg/kg, milligrams per milliliter, milligrams per milliliter, milligrams per milliliter, milligrams per milliliter, mg/mL, milligrams per milliliter, mg/mL, μg/mL, mg/mL, milligrams per milliliter, mg/mL, mg/mL,, milligrams per milliliter, milligrams per milliliter., milligrams per milliliter, mg/mL
Organism/Biological system, Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs)., Human umbilical vein endothelial cells (HUVECs), Mice, Human embryonic kidney cells (HEK293), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Escherichia coli, Human embryonic kidney cells (HEK293), Human umbilical vein endothelial cells (HUVECs), Human lymphocytes, Escherichia coli, Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs)., Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs)
Passage," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The GO particles had a particle size of 10 nm."""," ""The mean particle size of GO was 10.2 nm (Fig. 1). The HUVECs were exposed to 0.5 mg/mL GO for 24 h."""," ""The average particle diameter of GO was 5.2 nm (Figure 1). The MTT assay was used to evaluate the effect of GO on the viability of HUVECs. The results showed that GO at a concentration of 0.5 mg/mL significantly reduced cell viability (Figure 2)."""," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The particle size of GO was 10 nm.""", Histopathological examination of the lungs revealed that the airway diameter was decreased by 20% in the 0.5 mg/kg GO-treated group compared to the control group.," ""The particle size of GO was 10 nm, as determined by dynamic light scattering (DLS). The cytotoxicity of GO was evaluated using the MTT assay in human embryonic kidney cells (HEK293) with a GO concentration of 0.5 mg/mL."""," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The GO particles had an average size of 10 nm."""," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The GO particles had an average size of 10 nm."""," ""The mean particle size of GO was 10.2 nm. The cytotoxicity of GO was evaluated by MTT assay in human umbilical vein endothelial cells (HUVECs). The results showed that 0.5 mg/mL GO had no significant cytotoxicity"""," ""The cell diameter of E. coli decreased to 0.8 μm after treatment with 0.5 mg/mL graphene oxide."""," ""The particle size of GO was 10 nm, as determined by dynamic light scattering (DLS). The MTT assay was used to evaluate the cytotoxicity of GO on human embryonic kidney cells (HEK293). The cells were exposed to 0.5 mg/mL GO for 24 h."""," ""The particle size of GO was 10.2 nm (Fig. 1a) and the concentration of GO used in the MTT assay was 0.5 mg/mL."""," ""The mean nuclear diameter of the cells exposed to 0.5 μg/mL GO was 8.2 μm, which was significantly higher than that of the control cells (7.2 μm)."""," ""The results of the microbial growth inhibition assay showed that the growth of E. coli was inhibited in the presence of 0.5 mg/mL GO, as indicated by the decrease in the colony diameter from 0.5 mm to 0.2 mm"""," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The cells were exposed to GO with particle size of 10 nm at concentrations of 0.5 mg/mL for 24 h."""," ""The average particle size of GO was 10.2 nm (Fig. 1). The cytotoxicity of GO was evaluated using the MTT assay in human umbilical vein endothelial cells (HUVECs). The cells were exposed to 0.5 mg/mL GO for 24 h."""," ""The particle size of GO was 10.2 nm (Fig. 1). The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The cells were exposed to 0.5 mg/mL GO for 24 h."""," ""The particle size of GO was 10–20 nm, as determined by transmission electron microscopy (TEM). The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The cells were exposed to 0.1 mg/ml GO for 24 h."""," ""The cytotoxicity of GO was evaluated by MTT assay using human umbilical vein endothelial cells (HUVECs). The particle size of GO was 10 nm."""," ""The MTT assay was used to evaluate the cell viability of HUVECs after exposure to GO with a particle size of 10 nm at a dose of 0.5 mg/mL. The results showed that GO reduced cell viability in a dose-dependent manner (Figure 2)."""," ""The particle size of GO was 10 nm, as determined by dynamic light scattering (DLS). The GO dose used in the MTT assay was 0.5 mg/mL, which decreased cell viability in HUVECs"""," ""The average particle size of GO was 10.2 nm (Fig. S1). The cytotoxicity of GO was evaluated using the MTT assay with human umbilical vein endothelial cells (HUVECs). The cells were exposed to 0.5 mg/mL GO for 24 h."""
